CDC Updates Hepatitis B Vaccine Guidance for Newborns
The CDC revised hepatitis B vaccine recommendations for newborns, suggesting a delay until two months for babies whose mothers test negative for the virus.
Overview
A summary of the key points of this story verified across multiple sources.
- The CDC has updated its guidelines regarding the hepatitis B vaccine for all newborns, moving away from a universal recommendation for the birth dose.
- New guidance suggests waiting until at least two months of age for a baby's first hepatitis B shot if they do not receive the initial birth dose.
- This delayed vaccination is specifically recommended for infants born to mothers who have been confirmed negative for the hepatitis B virus.
- Despite the CDC's updated stance, pediatricians are still advised to recommend hepatitis B vaccination for all newborns as a standard practice.
- The change aims to provide flexibility in vaccination schedules while ensuring protection for infants at higher risk of exposure to hepatitis B.
Written by AI using shared reports from .
3 articles
Report issue

Read both sides in 5 minutes each day
Analysis
Compare how each side frames the story — including which facts they emphasize or leave out.
Center-leaning sources frame this story by emphasizing Illinois's decision to maintain universal newborn hepatitis B vaccination, portraying it as a successful public health policy. They highlight the "growing division" with federal guidance, presented as a source of "confusion." The framing prioritizes Illinois officials' rationale and data supporting their stance, largely omitting the federal government's reasoning for its revised recommendation.
Articles (3)
Compare how different news outlets are covering this story.
Center (2)
FAQ
Dig deeper on this story with frequently asked questions.
No FAQs available for this story.
History
See how this story has evolved over time.
- This story does not have any previous versions.


